Flucloxacillin Panpharma 500 mg, powder for solution for injection/infusion מלטה - אנגלית - Medicines Authority

flucloxacillin panpharma 500 mg, powder for solution for injection/infusion

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 500 mg - antibacterials for systemic use

Flucloxacillin Panpharma 250 mg, powder for solution for injection/infusion מלטה - אנגלית - Medicines Authority

flucloxacillin panpharma 250 mg, powder for solution for injection/infusion

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 250 mg - antibacterials for systemic use

Flucloxacillin Panpharma 1 g, powder for solution for injection/infusion מלטה - אנגלית - Medicines Authority

flucloxacillin panpharma 1 g, powder for solution for injection/infusion

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 1 g - antibacterials for systemic use

OPTALGIN  DROPS NEW ישראל - אנגלית - Ministry of Health

optalgin drops new

abic marketing ltd, israel - dipyrone - drops - dipyrone 500 mg / 1 ml - metamizole sodium - relief of moderate to severe pain as in headache, toothache, dysmenorrhea and for high fever that does not respond to other measures.

ANDROFEME 1 testosterone 1% w/v (10 mg/mL) cream tube אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

androfeme 1 testosterone 1% w/v (10 mg/ml) cream tube

lawley pharmaceuticals pty ltd - testosterone, quantity: 10 mg/ml - cream - excipient ingredients: almond oil; butylated hydroxytoluene; carbomer 940; cetomacrogol 1000; cetostearyl alcohol; citric acid; dl-alpha-tocopheryl acetate; trolamine; purified water; phenoxyethanol; propyl hydroxybenzoate; ethyl hydroxybenzoate; isobutyl hydroxybenzoate; butyl hydroxybenzoate; methyl hydroxybenzoate - androfeme 1 is indicated for the treatment of hypoactive sexual desire dysfunction (hsdd) in postmenopausal women. therapeutic intervention with androfeme 1 should only be initiated in women following failure of appropriate education and correction of modifiable biopsychosocial factors (which may include neuroendocrine imbalance, physical ill health or disease, interpersonal difficulties, psychological distress or specific cultural or religious beliefs), according to the international society for the study of women?s sexual health (isswsh) process of care (see figure 1).

NEBIDO INJECTION דרום אפריקה - אנגלית - South African Health Products Regulatory Authority (SAHPRA)

nebido injection

bayer (pty) ltd û isando - injection - see ingredients - each 4,0 ml solution contains testosterone undecanoate 1000,0 mg